Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
200 | 3 | ONCOLOGY//PACLITAXEL//THYMIDYLATE SYNTHASE | 52806 |
1497 | 2 | CISPLATIN//ISOLATED LIMB PERFUSION//IFOSFAMIDE | 7807 |
4566 | 1 | CISPLATIN//NEPHROTOXICITY//CISPLATIN NEPHROTOXICITY | 1792 |
5967 | 1 | IFOSFAMIDE//MESNA//TROFOSFAMIDE | 1580 |
10204 | 1 | ISOLATED LIMB PERFUSION//ISOLATED LIMB INFUSION//MELPHALAN | 1113 |
10574 | 1 | CARBOPLATIN//CALVERT FORMULA//CHATELUT FORMULA | 1081 |
11543 | 1 | CISPLATIN RESISTANCE//BUTHIONINE SULFOXIMINE//RAT OVARIAN TUMOR CELL LINES | 1000 |
14440 | 1 | ETOPOSIDE//ETOPOSIDE PHOSPHATE//ORAL ETOPOSIDE | 800 |
21477 | 1 | MELPHALAN//CHLORAMBUCIL//PREDNIMUSTINE | 441 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | CISPLATIN | authKW | 510527 | 15% | 11% | 1158 |
2 | ISOLATED LIMB PERFUSION | authKW | 388821 | 2% | 75% | 128 |
3 | IFOSFAMIDE | authKW | 382796 | 4% | 32% | 301 |
4 | NEPHROTOXICITY | authKW | 283011 | 6% | 14% | 492 |
5 | MELPHALAN | authKW | 238853 | 3% | 28% | 209 |
6 | MESNA | authKW | 167614 | 1% | 52% | 80 |
7 | ISOLATED LIMB INFUSION | authKW | 162186 | 1% | 93% | 43 |
8 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | journal | 156745 | 7% | 7% | 540 |
9 | ETOPOSIDE | authKW | 99688 | 3% | 11% | 222 |
10 | CARBOPLATIN | authKW | 92519 | 3% | 9% | 247 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 61236 | 46% | 0% | 3603 |
2 | Pharmacology & Pharmacy | 16122 | 28% | 0% | 2172 |
3 | Toxicology | 4102 | 8% | 0% | 589 |
4 | Urology & Nephrology | 1074 | 4% | 0% | 324 |
5 | Chemistry, Analytical | 755 | 6% | 0% | 450 |
6 | Chemistry, Medicinal | 556 | 3% | 0% | 256 |
7 | Medicine, Research & Experimental | 402 | 4% | 0% | 307 |
8 | Surgery | 387 | 6% | 0% | 478 |
9 | Biochemical Research Methods | 237 | 3% | 0% | 221 |
10 | Hematology | 167 | 2% | 0% | 176 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | SERV FARMACOL TOSSICOL | 32682 | 0% | 90% | 9 |
2 | DISCIPLINE ANAESTHET | 28245 | 0% | 100% | 7 |
3 | EXTRA CORPORAL CIRCULAT | 28245 | 0% | 100% | 7 |
4 | SURG METAB SECT | 25987 | 0% | 34% | 19 |
5 | DR DANIEL DEN HOED CANC | 17312 | 1% | 8% | 51 |
6 | EXPT SURG ONCOL | 16438 | 0% | 20% | 20 |
7 | IST ANAL TECNOL FARMACEUT | 16140 | 0% | 100% | 4 |
8 | KRIGO | 16140 | 0% | 100% | 4 |
9 | NIOMECH | 12105 | 0% | 100% | 3 |
10 | TRAUMA SURG MUSCULOSKELETAL SURG ONCOL | 12105 | 0% | 100% | 3 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 156745 | 7% | 7% | 540 |
2 | CANCER TREATMENT REPORTS | 15686 | 1% | 4% | 93 |
3 | ANTI-CANCER DRUGS | 10509 | 1% | 3% | 94 |
4 | CANCER RESEARCH | 8677 | 4% | 1% | 298 |
5 | CANCER TREATMENT REVIEWS | 8622 | 1% | 3% | 66 |
6 | EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 7357 | 1% | 3% | 59 |
7 | SEMINARS IN ONCOLOGY | 7271 | 1% | 2% | 98 |
8 | MELANOMA RESEARCH | 6354 | 1% | 3% | 54 |
9 | ANNALS OF SURGICAL ONCOLOGY | 5205 | 1% | 1% | 99 |
10 | ANTICANCER RESEARCH | 5047 | 2% | 1% | 160 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CISPLATIN | 510527 | 15% | 11% | 1158 | Search CISPLATIN | Search CISPLATIN |
2 | ISOLATED LIMB PERFUSION | 388821 | 2% | 75% | 128 | Search ISOLATED+LIMB+PERFUSION | Search ISOLATED+LIMB+PERFUSION |
3 | IFOSFAMIDE | 382796 | 4% | 32% | 301 | Search IFOSFAMIDE | Search IFOSFAMIDE |
4 | NEPHROTOXICITY | 283011 | 6% | 14% | 492 | Search NEPHROTOXICITY | Search NEPHROTOXICITY |
5 | MELPHALAN | 238853 | 3% | 28% | 209 | Search MELPHALAN | Search MELPHALAN |
6 | MESNA | 167614 | 1% | 52% | 80 | Search MESNA | Search MESNA |
7 | ISOLATED LIMB INFUSION | 162186 | 1% | 93% | 43 | Search ISOLATED+LIMB+INFUSION | Search ISOLATED+LIMB+INFUSION |
8 | ETOPOSIDE | 99688 | 3% | 11% | 222 | Search ETOPOSIDE | Search ETOPOSIDE |
9 | CARBOPLATIN | 92519 | 3% | 9% | 247 | Search CARBOPLATIN | Search CARBOPLATIN |
10 | ISOLATED HEPATIC PERFUSION | 89128 | 0% | 82% | 27 | Search ISOLATED+HEPATIC+PERFUSION | Search ISOLATED+HEPATIC+PERFUSION |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 2 |